Brevinin-2DYd

General Information


DRACP ID  DRACP04163

Peptide Name   Brevinin-2DYd

Sequence  GIFDVVKGVLKGVGKNVAGSLLEQLKCKLSGGC

Sequence Length  33

UniProt ID  P0C5X4 

PubChem CID  Not available

Origin  Synthetic

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C147H254N40O42S2

Absent amino acids  HMPRTWY

Common amino acids  G

Mass  388899

Pl  9.55

Basic residues  5

Acidic residues  2

Hydrophobic residues  13

Net charge  3

Boman Index  139

Hydrophobicity  49.09

Aliphatic Index  117.88

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  125

Absorbance 280nm  3.91

Polar residues  12

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 34073203

Title  Prediction of Anticancer Peptides with High Efficacy and Low Toxicity by Hybrid Model Based on 3D Structure of Peptides

Doi Not available

Year  2021

Literature 2

Pubmed ID 17688900

Title  Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii

Doi Not available

Year  2007

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  17933

DRACP is developed by Dr.Zheng's team.